Phibro Animal Health (NASDAQ:PAHC) Lowered to “Hold” Rating by StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

Other research analysts have also issued reports about the stock. Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Trading Up 0.6 %

Shares of NASDAQ PAHC opened at $21.64 on Tuesday. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock’s 50 day moving average price is $22.75 and its two-hundred day moving average price is $22.66. Phibro Animal Health has a 52-week low of $12.17 and a 52-week high of $26.55. The stock has a market capitalization of $876.48 million, a P/E ratio of 45.08, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Sterling Capital Management LLC boosted its position in shares of Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after buying an additional 448 shares during the period. Rhumbline Advisers raised its stake in Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after acquiring an additional 484 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares in the last quarter. BNP Paribas Financial Markets raised its stake in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the period. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.